Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Haemophilus influenzae type b Polysaccharide Capsule Conjugated to Tetanus Toxoid Carrier Protein (None)
- Target
- None
- Molecular classification
- Polysaccharide, Protein, Conjugate Vaccine
01
Overview
The target molecule is the capsular polysaccharide of Haemophilus influenzae type b (Hib), specifically polyribosyl-ribitol-phosphate (PRP), covalently conjugated to tetanus toxoid, a protein carrier. This conjugate is used in Hib vaccines to induce a robust and long-lasting immune response, especially in infants and young children.
- Other names
- Haemophilus influenzae type b capsular polysaccharide-tetanus toxoid conjugate vaccinePRP-T vaccine component
02
Mechanism of action
Induces protective anti-capsular antibodies via T-cell dependent B-cell activation and immunological memory.
03
Biological functions
Immune responseAntigen presentation
04
Disease associations
Infection
05
Safety considerations
Local redness/swelling at injection siteMild feverRare severe allergic reactions
06
Interacting drugs
Hib vaccines (various formulations)
Beyond the preview
Go deeper on Haemophilus influenzae type b Polysaccharide Capsule Conjugated to Tetanus Toxoid Carrier Protein (None).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Haemophilus influenzae type b Polysaccharide Capsule Conjugated to Tetanus Toxoid Carrier Protein (None).